Praxis Precision Medicines Inc (PRAX) support and resistance · rev $8.6M
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
This page maps Praxis Precision Medicines Inc (PRAX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
PRAX currently screens at market cap $7.38B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PRAX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PRAX quote page for the session range and the stock page for the full model.
Not investment advice.